Bio-Rad Laboratories (BIO) Change in Acquisitions & Divestments (2010 - 2026)

Bio-Rad Laboratories (BIO) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $126.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 53.79% year-over-year to $126.8 million in Q2 2026; TTM through Jun 2026 was $619.9 million, a 38.93% decrease from a year earlier, with the FY2025 full-year figure at $793.6 million, down 28.25% from the prior year.
• Change in Acquisitions & Divestments was $126.8 million for Q2 2026 at Bio-Rad Laboratories, down from $145.1 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $364.0 million in Q3 2024 and troughed at $45.8 million in Q1 2022.
• A 5-year average of $187.9 million and a median of $168.4 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments plunged 61.43% in 2023 and soared 257.41% in 2024, its largest moves.
• Over 5 years, Change in Acquisitions & Divestments stood at $165.6 million in 2022, then declined by 1.63% to $162.9 million in 2023, then rose by 26.18% to $205.5 million in 2024, then slipped by 28.27% to $147.4 million in 2025, then decreased by 13.98% to $126.8 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $126.8 million (Q2 2026), $145.1 million (Q1 2026), and $147.4 million (Q4 2025), per Business Quant data.